TheraRadar
Data updated: May 26, 2026

NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE (bacitracin zinc)

Corticosteroid Hormone Receptor Agonists
Infectious Disease Approved 1995-10-30

NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE is indicated for the treatment of Inflammatory Ocular Conditions; Bacterial Infection; Infective Conjunctivitis; Chronic Anterior Uveitis; Corneal Injury.

Source: FDA Label • BAUSCH AND LOMB
2
Indications
--
Phase 3 Trials
30
Years on Market

Details

Status
Prescription
First Approved
1995-10-30
Routes
OPHTHALMIC
Dosage Forms
OINTMENT

NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE Approval History

1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
21 FDA actions from 1995 to 2017
Mar 2017 SUPPL
Mfg · Manufacturing (CMC)
Jul 2012 ORIGINAL
Update
Aug 2002 SUPPL
Mfg · Manufacturing (CMC)

What NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE Treats

5 indications

NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE is approved for 5 conditions since its original approval in 1995. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Inflammatory Ocular Conditions
  • Bacterial Infection
  • Infective Conjunctivitis
  • Chronic Anterior Uveitis
  • Corneal Injury
Source: FDA Label

NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE

3 of 9

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

MAXITROL
DEXAMETHASONE
4 shared
HARROW EYE
Shared indications:
Inflammatory Ocular ConditionsInfective ConjunctivitisChronic Anterior Uveitis +1 more
LOTEPREDNOL ETABONATE AND TOBRAMYCIN
LOTEPREDNOL ETABONATE
3 shared
ALEMBIC
Shared indications:
Inflammatory Ocular ConditionsChronic Anterior UveitisCorneal Injury
TOBRADEX
DEXAMETHASONE
3 shared
Novartis
Shared indications:
Inflammatory Ocular ConditionsChronic Anterior UveitisCorneal Injury
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE FDA Label Details

Indications & Usage

NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE is indicated for the treatment of Inflammatory Ocular Conditions; Bacterial Infection; Infective Conjunctivitis; Chronic Anterior Uveitis; Corneal Injury.

Track NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.